
The Longevity Revolution: Medical Science Rewriting the Limits of Human Life
The medical field is shifting from treating diseases to intervening in the aging process itself. Senolytic therapy, CRISPR gene editing, and drugs such as rapamycin and metformin show real potential in early clinical trials — but this progress brings serious issues regarding access, inequality, and social system adjustments. This article outlines the scientific shift, ethical challenges, and critical developments that need to be monitored in this decade.


